|
|
High-flux hemodialysis combined with L-carnitine in treatment of 56 uremic patients with refractory anemia |
REN Yongqiang1,XUE Mei1,and CUI Zhiru2. |
1. Department of Nephrology, The Third Hospital of Beijing Municipal Corps,Chinese People’s Armed Police Forces,Beijing 100141,China;
2. Department of Nursing, Inner Mongolia Autonomous Region Corps Hospital, Chinese People’s Armed Police Forces, Hohehot 010040, China |
|
|
Abstract Objective To study the effect of high-flux hemodialysis combined with levocarnitine on uremic pationts with refractory anemia. Methods Fifty-six patients with refractory anemia in maintenance hemodialysis were randomly divided into 4 groups: normal group ( 14 cases) underwent conventional hemodialysis, 3 times a week; L-carnitine group (14 cases) was given levocarnitine 1 g on common hemodialysis basis, 3 times a week; high-flux dialysis group (14 cases) received high- flux hemodialysis,3 times a week; high-flux hemodialysis plus L-carnitine group (14 cases) was given levocarnitine 1 g on high-flux hemodialysis basis, 3 times a week. Blood routine and biochemical indicators were examined after treatment for 3 and 6 months, and statistical analysis was made. Results The conventional hemo dialysis group and L-carnitine group had no improvement in anemia; high-flux hemo dialysis group and high-flux hemodialysis plus L-carnitine group improved in anemia, with statistically significant difference, compared with the conventional hemodialysis group (P<0.05); high-flux hemodialysis combined with L-carnitine group, compared with high-flux hemodialysis group, had remarkable curative effect, with statistically significant difference ( P<0.05 ). Conclusion High-flux hemodialysis combined with L-carnitine is effective in the treatment of uremic patients with refractory anemia
|
Received: 01 March 2013
|
|
|
|
|
[1] |
雷建蓉.肾性贫血治疗的现状及展望[J].国外医学(移植与血液净化分册).2009.3(3):7-8.
|
[2] |
王海燕.肾脏病血[M].3版.北京:人民卫生出版社,2008:1908-1909.
|
[3] |
Ayli D,Ayli M,Azak A,et al.The effect of high-flux hemodialysis on renal anemia[J].Nephrol,2004,17(5):701-706.
|
[4] |
Locatelli F,Martin-Malo A,Hannedouche T,et al.Effect of membrane permeability on survival of hemodialysis patients [J].J Am Soc Nephrol,2009,20:645-654.
|
[5] |
侯 佳.高通量血液透析临床研究进展[J].新疆医学.2011.41(2):63-65.
|
[6] |
韩艳芳,彭立人.肉碱对氧化应激状态的影响[J].国际移植与血液净化杂志,2006,11(6):43-45.
|
[7] |
Bellinghieri G,Santoro D,Calvani M,et al.Carnitine and hemodialysis[J].Am J Kidey Dis,2003,41(3):116-121.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(6): 613-614. |
|
|
|
|